Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in miceTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42021-10-0115PREAI
Transmembrane bound-IL-15-promoted epithelial-mesenchymal transition in renal cancer cells requires the Src-dependent Akt/GSK3β/β-catenin pathway (vol 17, pg 410, 2015)NEOPLASIAIF7.72021-05-010OAAI
Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin PathwayNEOPLASIAIF7.72015-05-0139OAAI
Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analogBIOMEDICINE & PHARMACOTHERAPYIF7.52014-10-0149PREAI
Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulationBIOMEDICINE & PHARMACOTHERAPYIF7.52014-07-0152PREAI
Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 responseINTERNATIONAL IMMUNOPHARMACOLOGYIF4.72014-06-0173PREAI
Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancerBIOMEDICINE & PHARMACOTHERAPYIF7.52014-04-0134PREAI
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancerAUTOPHAGYIF14.32014-04-01237OAAI
Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signalingBIOMEDICINE & PHARMACOTHERAPYIF7.52013-06-0126PREAI